GLPG
Lakefront Biotherapeutics Nv
22/100
Smart-money confidence
Bottom band — money moving out
No standout activity across the feeds we track.
Stocks scoring 0–25 beat the S&P 500 39.9% of the time over the next three months, since 2015. How we measured this →
6
hedge funds
hold it · 3 added, 3 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Who's behind the signal
Every informed buyer we can see on GLPG, across all three feeds.
Hedge funds · 6
Greenlight Capital (Einhorn)
Increased +4%
Renaissance Technologies
Increased +29%
Millennium Management (Englander)
Increased +68%
Point72 (Steve Cohen)
Decreased −19%
D.E. Shaw & Co
Decreased −8%
Citadel Advisors
Decreased −29%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
LAKEFRONT BIOTHERAPEUTICS NV isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
0
New positions
3
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset
Pinch to zoom · drag sideways to move through time
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.3×
% of portfolio
0.3%
Position change
+4%
0.3% of Greenlight Capital's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+29%
0.0% of Renaissance Technologies's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+68%
0.0% of Millennium Management's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
−19%
0.0% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−8%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−29%
0.0% of Citadel Advisors's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to LAKEFRONT BIOTHERAPEUTICS NV
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell LAKEFRONT BIOTHERAPEUTICS NV or any security.